Literature DB >> 5575218

Causes of enucleation as seen in Jerusalem.

K L Batten.   

Abstract

Mesh:

Year:  1971        PMID: 5575218      PMCID: PMC1208215          DOI: 10.1136/bjo.55.3.174

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  2 in total

1.  [Data and comments on enucleation of the eye. Studies on the patients of the Universitaets-Augenklinik Basel 1930-1954].

Authors:  P B AMMANN
Journal:  Taehan Naekwa Hakhoe Chapchi       Date:  1962-03

2.  Tumors of the eye and adnexa in Africans of Uganda.

Authors:  A C Templeton
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

  2 in total
  6 in total

1.  Destructive ophthalmic procedures, a comparison between a developed and a developing country.

Authors:  A Shapiro; M B Monselise
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-09-11

2.  A survey of satisfaction in anophthalmic patients wearing ocular prosthesis.

Authors:  Jong-Suk Song; Jaeryung Oh; Se Hyun Baek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-17       Impact factor: 3.117

3.  Clinicopathological review of 1146 enucleations (1980-90).

Authors:  P de Gottrau; L M Holbach; G O Naumann
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

4.  Indications for destructive eye surgeries at the Yaounde Gynaeco-Obstetric and Paediatric Hospital.

Authors:  André Omgbwa Eballé; Viola Andin Dohvoma; Godefroy Koki; Abdouramani Oumarou; Assumpta Lucienne Bella; Côme Ebana Mvogo
Journal:  Clin Ophthalmol       Date:  2011-05-05

5.  Enucleation and evisceration in the palestinian territories.

Authors:  Tiarnan D L Keenan; Nicholas J Sargent
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

6.  Enucleation and evisceration at a tertiary care hospital in a developing country.

Authors:  Osama H Ababneh; Eman A AboTaleb; Mohammad A Abu Ameerh; Yacoub A Yousef
Journal:  BMC Ophthalmol       Date:  2015-09-11       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.